RPN1, a new reference gene for quantitative data normalization in lung and kidney cancer

Molecular Biology

Volumn 45, Issue 2, 2011, Pages 211-220

  Krasnov, G S ^a   Oparina, N Yu ^a   Dmitriev, A A ^a   Kudryavtseva, A V ^a   Anedchenko, E A ^a   Kondrat'eva, T T ^b   Zabarovsky, E R ^c   Senchenko, V N ^a  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

clear cell renal cancer; nonsmall cell lung cancer; normalization; reference genes; ribophorin

Indexed keywords

EID: 79955574331     PISSN: 00268933     EISSN: 16083245     Source Type: Journal    
DOI: 10.1134/S0026893311020129     Document Type: Article

References (41)

1. Lonneborg A., Aaroe J., Dumeaux V., Borresen-Dale A. L. 2009. Found in transcription: Gene expression and other novel blood biomarkers for the early detection of breast cancer. Expert. Rev. Anticancer Ther. 9, 1115-1123.
2. Delgado M. D., Leon J. 2006. Gene expression regulation and cancer. Clin. Transl. Oncol. 8, 780-787.
3. t method. Methods. 25, 402-408.
4. Pfaffl M. W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
5. Vandesompele J., de Preter K., Pattyn F., Poppe B., van Roy N., de Paepe A., Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034.
6. Huggett J., Dheda K., Bustin S., Zumla A. 2005. Real-time RT-PCR normalisation: Strategies and considerations. Genes Immun. 6, 279-284.
7. Skrzypski M. 2008. Quantitative reverse transcriptase real-time polymerase chain reaction (qRT-PCR) in translational oncology: Lung cancer perspective. Lung Cancer. 59, 147-154.
8. Tricarico C., Pinzani P., Bianchi S., Paglierani M., Distante V., Pazzagli M., Bustin S. A., Orlando C. 2002. Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal. Biochem. 309, 293-300.
9. Lallemant B., Evrard A., Combescure C., Chapuis H., Chambon G., Raynal C., Reynaud C., Sabra O., Joubert D., Hollande F., Lallemant J. G., Lumbroso S., Brouillet J. P. 2009. Reference gene selection for head and neck squamous cell carcinoma gene expression studies. BMC Mol. Biol. 10, 78.
10. Toegel S., Huang W., Piana C., Unger F. M., Wirth M., Goldring M. B., Gabor F., Viernstein H. 2007. Selection of reliable reference genes for qPCR studies on chondroprotective action. BMC Mol. Biol. 8, 13.
11. Kidd M., Nadler B., Mane S., Eick G., Malfertheiner M., Champaneria M., Pfragner R., Modlin I. 2007. GeneChip, geNorm, and gastrointestinal tumors: Novel reference genes for real-time PCR. Physiol. Genomics. 30, 363-370.
12. Hellemans J., Mortier G., de Paepe A., Speleman F., Vandesompele J. 2007. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 8, R19.
13. Pfaffl M. W., Tichopad A., Prgomet C., Neuvians T. P. 2004. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper-Excel-based tool using pair-wise correlations. Biotechnol. Lett. 26, 509-515.
14. Andersen C. L., Jensen J. L., Orntoft T. F. 2004. Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64, 5245-5250.
15. Liu D. W., Chen S. T., Liu H. P. 2005. Choice of endogenous control for gene expression in nonsmall cell lung cancer. Eur. Respir. J. 26, 1002-1008.
16. Gresner P., Gromadzinska J., Wasowicz W. 2009. Reference genes for gene expression studies on non-small cell lung cancer. Acta Biochim. Pol. 56, 307-316.
17. Saviozzi S., Cordero F., Lo Iacono M., Novello S., Scagliotti G. V., Calogero R. A. 2006. Selection of suitable reference genes for accurate normalization of gene expression profile studies in non-small cell lung cancer. BMC Cancer. 6, 200.
18. Glenn S. T., Jones C. A., Liang P., Kaushik D., Gross K. W., Kim H. L. 2007. Expression profiling of archival renal tumors by quantitative PCR to validate prognostic markers. Biotechniques. 43, 639-640, 642-643, 647.
19. Jung M., Ramankulov A., Roigas J., Johannsen M., Ringsdorf M., Kristiansen G., Jung K. 2007. In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR. BMC Mol. Biol. 8, 47.
20. Kudriavtseva A. V., Anedchenko E. A., Oparina N. Yu., Krasnov G. S., Kashkin K. N., Dmitriev A. A., Zborovskaya I. B., Kondratjeva T. T., Vinogradova E. V., Zinovyeva M. V., Kopantsev E. P., Senchenko V. N. 2009. Expression of FTL and FTH genes encoding ferritin subunits in lung and renal carcinomas. Mol. Biol. (Moscow). 43, 972-981.
21. Anedchenko E. A., Dmitriev A. A., Krasnov G. S., Kondratieva T. T., Kopantsev E. P., Vinogradova T. V., Zinovyeva M. V., Zborovskaya I. B., Polotsky B. E., Sakharova O. V., Kashuba V. I., Zabarovsky E. R., Senchenko V. N. 2008. Downregulation of RBSR3/CTDSRL, NRRL2/G21, RASSF1A, ITGA9, HYAL1, and HYAL2 in non-small cell lung cancer. Mol. Biol. (Moscow). 42, 859-869.
22. Senchenko V. N., Anedchenko E. A., Kondratieva T. T., Krasnov G. S., Dmitriev A. A., Zabarovska V. I., Pavlova T. V., Kashuba V. I., Lerman M. I., Zabarovsky E. R. 2010. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21, and RASSF1A in primary non-small cell lung cancer. BMC Cancer. 10, 75.
23. dbEST; http://www. ncbi. nlm. nih. gov/sites/entrez?db=nucest.
24. University of California Santa Cruz; http://www. genome. ucsc. edu/.
25. She X., Rohl C. A., Castle J. C., Kulkarni A. V., Johnson J. M., Chen R. 2009. Definition, conservation and epigenetics of housekeeping and tissue-enriched genes. BMC Genomics. 10, 269.
26. Rhodes D. R., Yu J., Shanker K., Deshpande N., Varambally R., Ghosh D., Barrette T., Pandey A., Chinnaiyan A. M. 2004. ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia. 6, 1-6.
27. Oncomine; http://www. oncomine. org/.
28. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer; http://cgap. nci. nih. gov/Chromosomes/Mitelman.
29. Al-Shahrour F., Carbonell J., Minguez P., Goetz S., Conesa A., Tarraga J., Medina I., Alloza E., Montaner D., Dopazo J. 2008. Babelomics: advanced functional profiling of transcriptomics, proteomics and genomics experiments. Nucleic Acids Res. 36, W341-W346.
30. Pavlova T. V., Kashuba V. I., Muravenko O. V., Yenamandra P. S., Ivanova T. A., Zabarovska V. I., Pakhmanaliev E. R., Petrenko L. A., Pronina I. V., Loginova V. I., Yurkevich O. Yu., Kisselev L. L., Zelenin A. V., Zabarovsky E. R. 2009. Use of NotI microarrays in analysis of epigenetic and structural changes in epithelial tumor genomes by the example of human chromosome 3. Mol. Biol. (Moscow). 43, 313-320.
31. Anedchenko E. A., Kisseljova N. P., Dmitriev A. A., Kisseljov F. L., Zabarovsky E. R., Senchenko V. N. 2007. Tumor suppressor gene RBSR3 in cervical carcinoma: Copy number and transcription level. Mol. Biol. (Moscow). 41, 77-85.
32. Wang F., Grigorieva E. V., Li J., Senchenko V. N., Pavlova T. V., Anedchenko E. A., Kudryavtseva A. V., Tsimanis A., Angeloni D., Lerman M. I., Kashuba V. I., Klein G., Zabarovsky E. R. 2008. HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro. PLoS One. 3, e3031.
33. Wilson C. M., Kraft C., Duggan C., Ismail N., Crawshaw S. G., High S. 2005. Ribophorin I associates with a subset of membrane proteins after their integration at the sec61 translocon. J. Biol. Chem. 280, 4195-4206.
34. Wilson C. M., High S. 2007. Ribophorin I acts as a substrate-specific facilitator of N-glycosylation. J. Cell. Sci. 120, 648-657.
35. Wilson C. M., Roebuck Q., High S. 2008. Ribophorin I regulates substrate delivery to the oligosaccharyltransferase core. Proc. Natl. Acad. Sci. U. S. A. 105, 9534-9539.
36. Sanchez-Carbayo M., Socci N. D., Lozano J., Saint F., Cordon-Cardo C. 2006. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J. Clin. Oncol. 24, 778-789.
37. Welsh J. B., Zarrinkar P. P., Sapinoso L. M., Kern S. G., Behling C. A., Monk B. J., Lockhart D. J., Burger R. A., Hampton G. M. 2001. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. U. S. A. 98, 1176-1181.
38. Welsh J. B., Sapinoso L. M., Su A. I., Kern S. G., Wang-Rodriguez J., Moskaluk C. A., Frierson H. F. Jr., Hampton G. M. 2001. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61, 5974-5978.
39. Valk P. J., Verhaak R. G., Beijen M. A., Erpelinck C. A., Barjesteh van Waalwijk van Doorn-Khosrovani S., Boer J. M., Beverloo H. B., Moorhouse M. J., van der Spek P. J., Lowenberg B., Delwel R. 2004. Prognostically useful gene-expression profiles in acute myeloid leukemia. N. Engl. J. Med. 350, 1617-1628.
40. Demirhan O., Tastemir D., Hasturk S., Kuleci S., Hanta I. 2010. Alterations in p16 and p53 genes and chromosomal findings in patients with lung cancer: Fluorescence in situ hybridization and cytogenetic studies. Cancer Epidemiol. 34, 472-477.
41. Gronbaek K., Hother C., Jones P. A. 2007. Epigenetic changes in cancer. Acta Pathol. Microbiol. Immuniol. Scand. 115, 1039-1059.